Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV

There is uncertainty regarding the potential virologic outcome associated with a change in antiretroviral therapy (ARV) among PLHIV who had previous documented virologic failure or who have been exposure to mono/dual nucleoside reverse transcriptase inhibitors (NRTI) therapy. The objective was to me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicine (Baltimore) 2020-11, Vol.99 (47), p.e23335-e23335, Article 23335
Hauptverfasser:	Sangaré, Mohamed N’dongo, Baril, Jean-Guy, de Pokomandy, Alexandra, Laprise, Claudie, Deshaies, Catherine, Klein, Marina, Thomas, Réjean, Tremblay, Cécile, Roger, Michel, Pexos, Costa, Greenwald, Zoe, Machouf, Nima, Durand, Madeleine, Hardy, Isabelle, Dakouo, Mamadou, Laporte, Louise, Trottier, Helen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral Therapy, Highly Active Drug Resistance, Viral Female General & Internal Medicine Heterocyclic Compounds, 3-Ring - therapeutic use HIV Infections - drug therapy HIV Infections - virology HIV Integrase Inhibitors - therapeutic use Humans Life Sciences & Biomedicine Male Medicine, General & Internal Middle Aged Observational Study Oxazines - therapeutic use Piperazines - therapeutic use Pyridones - therapeutic use Quebec Reverse Transcriptase Inhibitors - therapeutic use Science & Technology Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!